IXHL
INCANNEX HEAL (IXHL)
NASDAQ
$3.22+$0.01 (+0.34%)
Price as of Oct 02, 2026 7:58 PM EDT
  • $38.4M
    Market Cap
  • -77.79%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
06/30/2026
06/30/2025
06/30/2024
06/30/2023
Income Statement
Total Operating Revenue
0
-100.00%
86,000
+616.67%
12,000
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
86,000
+616.67%
12,000
N/A
0
+100.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
1.9M
-32.55%
Research and Development Expense
-5.2M
-51.52%
-10.7M
-16.55%
-12.9M
+37.53%
-9.4M
+74.33%
Depreciation and Amortization Expense
240,000
-2.44%
246,000
+138.83%
103,000
N/A
N/A
N/A
Total Operating Expenses
23.0M
-3.55%
23.9M
-20.56%
30.1M
N/A
N/A
N/A
Operating Profit
-23.0M
-3.20%
-23.8M
-20.81%
-30.0M
N/A
N/A
N/A
Interest Income
21,000
-66.13%
62,000
-69.90%
206,000
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
21,000
-66.13%
62,000
-69.90%
206,000
N/A
0
N/A
Total Nonoperating Income and Expense
3.7M
+116.13%
-23.1M
-298.90%
11.6M
+743.50%
1.4M
+1,784.03%
Income before Taxes
-19.3M
-58.83%
-46.9M
+154.41%
-18.4M
-7.76%
-20.0M
+34.06%
Income Taxes
0
N/A
N/A
N/A
30,000
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-19.3M
-58.83%
-46.9M
+154.00%
-18.5M
-7.61%
-20.0M
+34.06%
Net Income from Continuing Operations Applicable to Common
-19.3M
-58.83%
-46.9M
+154.41%
-18.4M
-7.76%
-20.0M
+34.06%
Basic EPS and Net Income
-1.66
+22.96%
-1.35
+17.39%
-1.15
-11.54%
-1.30
+4.00%
Diluted EPS and Net Income
-1.66
+22.96%
-1.35
+17.39%
-1.15
-11.54%
-1.30
+4.00%
Basic Weighted Average Shares
11.7M
-66.16%
34.5M
+113.15%
16.2M
-98.95%
1.5B
+109,673.36%
Diluted Weighted Average Shares
11.7M
-66.16%
34.5M
+113.15%
16.2M
-98.95%
1.5B
+109,673.36%
Balance Sheet
Cash and Cash Equivalents
67.7M
+350.24%
15.0M
+156.73%
5.9M
-82.44%
33.4M
-11.03%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
67.7M
+350.24%
15.0M
+156.73%
5.9M
-82.44%
33.4M
-11.03%
Total Current Assets
72.8M
+264.83%
20.0M
+23.21%
16.2M
-53.29%
34.7M
-8.43%
Accumulated Depreciation
643,000
+139.03%
269,000
+113.49%
126,000
N/A
N/A
N/A
Property and Plant and Equipment and Net
4,000
-98.24%
227,000
-51.91%
472,000
+6.39%
443,652
N/A
Total Long-Term Assets
4,000
-98.24%
227,000
-51.91%
472,000
-99.12%
53.9M
+64,102.97%
Total Assets
73.0M
+256.92%
20.4M
+19.94%
17.0M
-80.76%
88.6M
+133.87%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
1.5M
-78.64%
7.0M
+24.27%
5.6M
+46.14%
3.8M
+91.28%
Total Long-Term Debt
100,000
0.00%
100,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
34,000
-54.05%
74,000
-64.76%
210,000
-65.91%
616,087
N/A
Total Liabilities
5.6M
-20.57%
7.1M
+21.06%
5.8M
+30.66%
4.5M
+121.92%
Retained Earnings
-176.9M
+12.25%
-157.6M
+42.36%
-110.7M
+40.49%
-78.8M
+33.98%
Total Stockholders Equity
67.4M
+403.20%
13.4M
+19.36%
11.2M
-86.67%
84.1M
+134.54%
Total Shares Outstanding
12.5M
-93.55%
194.4M
+1,124.59%
15.9M
N/A
N/A
N/A
Cash Flow
Cash from Operating Activities
-12.9M
+2.83%
-12.5M
-21.03%
-15.8M
-0.61%
-15.9M
+24.48%
Capital Expenditures
10,000
+25.00%
8,000
-97.11%
277,000
N/A
N/A
N/A
Cash from Investing Activities
-94,000
+1,075.00%
-8,000
-97.11%
-277,000
-41.91%
-476,873
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
65.9M
+208.02%
21.4M
N/A
N/A
N/A
12.3M
-70.19%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-27,661.63%
-88.95%
-250,341.67%
N/A
N/A
N/A
Return on Assets
-41.32%
-83.48%
-250.09%
+615.62%
-34.95%
+10.61%
-31.60%
N/A
Return on Equity
-47.80%
-87.46%
-381.09%
+884.21%
-38.72%
+16.28%
-33.30%
N/A
Revenue Growth
-100.00%
-116.22%
616.67%
N/A
N/A
N/A
N/A
N/A
Current Ratio
48.81
+1,607.78%
2.86
-0.86%
2.88
-68.04%
9.02
N/A
Cash Ratio
45.38
+2,007.49%
2.15
+106.60%
1.04
-87.99%
8.68
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow